The clinical picture, risk factors and natural history of tardive dystonia
resulting from dopamine-receptor antagonist (DRA) treatment in 107 patients
(57 male and 50 female), seen between 1972 and 1995, are described. The me
an age at onset(+/- SD) was 38.3 +/- 13.7 years (range 13-68 years), and th
e age at last follow-up was 46.3 +/- 15.7 years (range 15-80 years). These
patients had received DRAs for schizophrenia (39%), for other psychiatric c
onditions (51.5%) and for non-psychiatric disorders (9.5%). All classes of
neuroleptics used were implicated in producing tardive dystonia, which was
found to develop at any time, ranging from 4 days to 23 years after their i
ntroduction (median 5, mean 6.2 +/- 5.1 years); there was no 'safe' period.
Men were significantly younger than women at onset of dystonia, which deve
loped after shorter exposure in men. At onset, the dystonia was focal in 83
% of cases, but progressed over months or years and remained focal in only
17% at the time of maximum severity. The craniocervical region was involved
in 87% of cases, and was the most commonly affected site both at onset and
at maximum severity. There was a correlation between the site and age of o
nset; the site of onset ascended from the lower limbs to the face as the me
an age of onset increased.